←Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma
Stephen Schuster
MD
🏢University of Pennsylvania Abramson Cancer Center🌐USA
Robert and Margarita Louis-Dreyfus Professor
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Stephen Schuster is a lymphoma leader at Penn and principal investigator of pivotal mosunetuzumab and tisagenlecleucel trials. He has led trials shaping both CAR-T and bispecific standards in DLBCL and FL. His work has transformed relapsed B-cell lymphoma therapy.
Share:
🧪Research Fields 研究领域
mosunetuzumab follicular lymphoma
bispecific antibodies
CAR-T lymphoma
DLBCL
tisagenlecleucel
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Stephen Schuster 的研究动态
Follow Stephen Schuster's research updates
留下邮箱，当我们发布与 Stephen Schuster（University of Pennsylvania Abramson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment